Merkoša sitáhtat

APA-čujuhus (7. p.)
J, B., Y, W., K, Z., & H, Q. (2022). AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma. Dove Medical Press.
Chicago-čujuhus (17. p.)
J, Bao, Wu Y, Zhang K, juo Qi H. AC099850.3/NCAPG Axis Predicts Poor Prognosis and Is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma. Dove Medical Press, 2022.
MLA-čujuhus (9. p.)
J, Bao, et al. AC099850.3/NCAPG Axis Predicts Poor Prognosis and Is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma. Dove Medical Press, 2022.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.